Nasdaq
MLYS
Mineralys Therapeutics, Inc.
- Health Care
- Listed 2023
- 1 day
- +0.5%
- 1 month
- −11.4%
- 1 year
- +101%
$26.99 · Mkt cap $2.23B
At the 6 Aug 2026 close
Nasdaq
Mineralys Therapeutics, Inc.
$26.99 · Mkt cap $2.23B
At the 6 Aug 2026 close
Mineralys Therapeutics, Inc. trades under the ticker MLYS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2023. Its market capitalisation is $2.23B. The last closing price was $26.99, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +101%, and −11.4% over the past month. Returns are price returns and exclude dividends.
This page exists because MLYS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.